• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Cardiology

Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

byKathleen LauandAlex Chan
July 29, 2020
in Cardiology, Infectious Disease, Pulmonology
Reading Time: 2 mins read
Share on FacebookShare on Twitter

Click to read the study in CMAJ

1. In patients positive for COVID-19 suffering cardiac injury, cardiac troponin (cTnI) levels were associated with poor survival, with peak cTnI levels shown to predict the need for invasive ventilation.

Evidence Rating Level: 2 (Good)

Reports show that patients with COVID-19-associated pneumonia and cardiac injury experience poor outcomes, but whether they were discharged or died remained uncharacterized as the pandemic was ongoing. Additionally, the arrhythmia burden in those admitted to the ICU was estimated at 44.4%, but the nature of these arrhythmias was also largely unknown. Studying data from the Wuhan outbreak, which had run its full course, could allow for identification of independent predictors of poor outcomes (ie need for invasive ventilation) and characterization of these arrhythmias.This retrospective cohort study included 1284 patients with severe COVID-19, defined as viral-positive patients who had CT-confirmed pneumonia, that were admitted to Tongji Hospital in Wuhan, China from Jan 29 to March 8, 2020. Of those, 1159 patients had their cTNI measured within 72 hours of admission and 170 patients with cardiac injury (cTNI >26.2pg/mL) were included (n=49 discharged alive, median 61.5yo, 16% male, onset of illness median 11 days; n=121 died, median 64yo, 77% male, onset of illness median 11 days) were included. Those patients with cardiac injury had a mortality rate over 10 times higher than those without elevated cTNI (71.2% vs 6.6%, p<0.001). Even after adjusting for age, sex, and usage of QT-prolonging medications, both initial (per 10-fold increase, HR 1.32, 95% CI 1.06-1.66) and peak cTNI levels (per 10-fold increase, HR 1.70, 95% CI 1.38-2.10) during hospital stay were associated with poor survival. Furthermore, peak cTNI levels were an independent predictor for needing invasive ventilatory support (OR 3.02, 95% CI 1.92-4.98). As well, 53 arrhythmia episodes were recorded on ECGs among 60 of the patients with cardiac injury (35 patients with atrial arrhythmias only, 2 ventricular only, 7 both), an association not previously seen with SARS or MERS. With 35 patients experiencing only atrial arrhythmias. Overall, patients who died in hospital had more dyspnea (51.2% vs 30.6%, p=0.02), a greater need for mechanical ventilation (66.9% vs 4.1%, p<0.001), and higher levels of cTNI (393.8 vs 48.5 pg/mL, p<0.001). Data on patients without cardiac injury, other than mortality, could not be accessed and whether patients developed cardiac injury past the first 72 hours after admission was not considered. Nonetheless, these findings support assessing cTNI levels in patients with COVID-19, undergoing therapy that prolongs repolarization.

Image: PD

©2020 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

Tags: arrhythmiascardiologypulmonologySARS-CoV-2
Previous Post

Hydroxychloroquine not beneficial for early, mild COVID-19

Next Post

Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

The mortality in-hospital for patients undergoing elective catheter ablation for atrial fibrillation is low

September 4, 2026
Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial
Cardiology

A medical care at home program following hospitalization with acute decompensated heart failure may offer a safe and effective alternative to continued hospitalization

July 24, 2026
Rivaroxaban likely reduces risk of recurrent stroke in specific subgroup of patients with embolic stroke of undetermined source
Cardiology

Catheter ablation within 1 year of atrial fibrillation diagnosis is associated with reduced risk of recurrence

July 24, 2026
Next Post
Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

Death, discharge and arrhythmias among patients with COVID-19 and cardiac injury

Survival greater in cervical cancer patients undergoing abdominal hysterectomy compared to minimally invasive techniques: the LACC trial

Robot-assisted hernia repairs produce patient outcomes comparable to laparoscopic repairs

#VisualAbstract: Treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid

#VisualAbstract: Treating latent tuberculosis infection with four months of rifampin versus nine months of isoniazid

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Rimegepant (Nurtec ODT) may be an effective alternative to triptans for symptom relief in migraines
  • Dexmedetomidine (Precedex) may offer similar analgesic efficacy as remifentanil (Ultiva) with fewer adverse effects in adults undergoing sleeve gastrectomy
  • The Scan by 2 Minute Medicine®: Sugary drinks track with higher depression risk while coffee shows the opposite, US measles cases reach their highest level in decades, peptide injections fuel the next wellness craze, and most routine blood tests do not require prolonged fasting
License Content
Terms of Use | Disclaimer
Cookie Policy
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.